Older people who regularly drink green tea have fewer brain lesions are characteristic of dementia than those who do not ...

The FDA has issued a complete response letter to the biologics license application seeking the approval of tabelecleucel for ...

Failed to fetch dynamically imported module: https://sg.finance.yahoo.com/assets/_app/immutable/nodes/98.Bghnd5-7.js ...

As per NPJ - Science of Food, participants who drank 600 ml of green tea as compared to a consumption level of 200 ml had 3% less brain damage.

Shares of Atara Biotherapeutics, Inc. (NASDAQ:ATRA) tumbled 51% after the company disclosed receiving a Complete Response ...

On the third day, drugmakers provided updates on precision medicines for cancer and Alzheimer's, and Grail talked about the launch of a new version of the Galleri test.

Atara Biotherapeutics, Inc. , a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer ...

Investing.com -- Atara Biotherapeutics, Inc. (NASDAQ:ATRA)股价暴跌51%，此前该公司披露收到美国食品和药物管理局（FDA）就其EBVALLOTM（tabelecleucel）治疗发出的完整回复函（CRL）。这份CRL涉及用于某些Epstein-Barr病毒阳性移植后淋巴增殖性疾病（EBV+ ...